Jennison Associates LLC’s Eli Lilly & Co Position
Does Jennison Associates LLC own Eli Lilly & Co (LLY)? Yes — 5.06M shares worth $4.7B (+3.20% of its 13F portfolio) as of Q1 2026, down from 5.13M shares the prior filed quarter.
Position Value
$4.7B
Q1 2026
Shares
5.06M
% of Portfolio
+3.20%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.06M | $4.7B | +3.20% |
| Q4 2025 | 5.13M | $5.5B | +3.31% |
| Q3 2025 | 4.20M | $3.2B | +1.86% |
| Q2 2025 | 5.45M | $4.2B | +2.52% |
| Q1 2025 | 5.22M | $4.3B | +3.02% |
| Q4 2024 | 4.80M | $3.7B | +2.25% |
| Q3 2024 | 6.95M | $6.2B | +3.82% |
| Q2 2024 | 7.23M | $6.5B | +4.20% |
| Q1 2024 | 7.47M | $5.8B | +3.88% |
| Q4 2023 | 7.60M | $4.4B | +3.30% |
| Q3 2023 | 8.41M | $4.5B | +3.83% |
| Q2 2023 | 8.58M | $4.0B | +3.30% |
| Q1 2023 | 8.57M | $2.9B | +2.70% |
| Q4 2022 | 10.43M | $3.8B | +3.87% |
| Q3 2022 | 10.06M | $3.3B | +3.24% |
| Q2 2022 | 10.36M | $3.4B | +3.35% |
| Q1 2022 | 7.90M | $2.3B | +1.67% |
| Q4 2021 | 9.16M | $2.5B | +1.60% |
| Q3 2021 | 9.86M | $2.3B | +1.47% |
| Q2 2021 | 8.91M | $2.0B | +1.36% |
| Q1 2021 | 5.44M | $1.0B | +0.74% |
| Q4 2020 | 1.88M | $317M | +0.23% |
| Q3 2020 | 4.58M | $678M | +0.55% |
| Q2 2020 | 8.06M | $1.3B | +1.20% |
| Q1 2020 | 10.19M | $1.4B | +1.72% |
| Q4 2019 | 4.51M | $593M | +0.60% |
| Q3 2019 | 1.36M | $152M | +0.16% |
| Q2 2019 | 1.57M | $174M | +0.17% |
| Q1 2019 | 3.65M | $474M | +0.47% |
| Q4 2018 | 3.43M | $396M | +0.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jennison Associates LLC’s full portfolio or all institutional holders of LLY.